Evidence map›Paper›PMID 42416309›Full record

ReviewFrontiers in oral health2026

Treatments in oral lichen planus: a review.

Ce Gou, Qinghua Zhang, Zhijun Zhang

Abstract readReview
In one paragraph

Review in Frontiers in oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ce Gou *School of Clinical Medical, Chengdu Medical College, Chengdu, China.
Qinghua Zhang *School of Clinical Medical, Chengdu Medical College, Chengdu, China.
Zhijun ZhangSchool of Clinical Medical, Chengdu Medical College, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral lichen planus is a chronic inflammatory disease of the oral mucosa characterized by pain and burning sensation. The etiology of OLP is complex and multifactorial, leading to recurrence and a lack of clear treatment methods. Drug therapy, including corticosteroids, calcineurin inhibitors, hydroxychloroquine, hyaluronic acid, and mTOR inhibitors, as well as non pharmacological treatments such as autologous platelet concentrates and photodynamic therapy, are the pillars of clinical management. This review is based on 46 articles published between 2020 and 2025, examining current treatment strategies and proposing innovative recommendations to strengthen existing treatments. This study provides new insights into drug combination strategies and non drug alternative treatment options for treating OLP, laying the foundation for future research and clinical trials aimed at developing more effective and personalized treatment plans.

Indexed as

combination therapynonpharmacological treatmentoral lichen planuspharmacological treatmentreplacement therapy

Identifiers

PMID42416309
PMCPMC13337697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.